by Richard Daverman, PhD
February 26, 2013 -- Crystal Pharmatech, a Suzhou CRO, has announced it will partner with Particle Sciences, a CRO based in New Jersey. The partnership will focus on dealing with new drug molecules that have insoluability problems. The partnership is the second that Crystal Pharma has formed in as many months. In January, Crystal and US-based Xceleron teamed up to collaborate on the pharmacokinetics of development-stage drugs. More details....
